Latest News about Briefs
Recent news which mentions Briefs
From Benzinga
Jones Soda Reports Wider Quarterly Loss Driven By Lower Sales Volume, Inventory Write-Off
April 01, 2025
From Benzinga
From Benzinga
US Judge Rejects Another Johnson & Johnson Attempt To Use Bankruptcy For Talc Cancer Claims
April 01, 2025
From Benzinga
What's Going On With Rigetti Computing Stock Today?
April 01, 2025
From Benzinga
From Benzinga
From Benzinga
What's Going On With Kroger Stock Today?
April 01, 2025
From Benzinga
EXCLUSIVE: Capstone Clocks 8% Q4 Revenue Growth, Aims For $100 Million Revenue Run Rate By 2025
April 01, 2025
From Benzinga
Chevron Divests 70% Stake In East Texas Gas Assets: Details
April 01, 2025
From Benzinga
What's Going On With IonQ Stock Today?
April 01, 2025
From Benzinga
From Benzinga
From Benzinga
Asia Markets Mixed, Europe Rebounds Amid Tariff Uncertainty, Gold Hits New High - Global Markets Today While US Slept
April 01, 2025
From Benzinga
From Benzinga
Shoptalk 2025: Goldman Sachs Analyst Unveils Insights On AI, Video, Retail And Stock Picks
March 31, 2025
From Benzinga
Vertex Discontinues Development Of Type 1 Diabetes Candidate After Disappointing Data
March 31, 2025
From Benzinga
Corcept Therapeutics Stock Jumps On Upbeat Ovarian Cancer Trial Data, Analysts Boost Price Forecast
March 31, 2025
From Benzinga
Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating
March 31, 2025
From Benzinga
Gold Rally Could Gain Momentum With Central Bank Buying And China Allocation, Analyst Says
March 31, 2025
From Benzinga
From Benzinga
FDA Approves AstraZeneca's Imfinzi As First Perioperative Immunotherapy For Muscle-Invasive Bladder Cancer Patients
March 31, 2025
From Benzinga
From Benzinga
CAVA Can Outgrow Expectations With Strong Unit Economics And Market Headroom, Analyst Says
March 31, 2025
From Benzinga
Rocket Fuels Mortgage Empire With $9.4 Billion Mr. Cooper Acquisition—One In Six US Mortgages Now Under Its Roof
March 31, 2025
From Benzinga
From Benzinga
Palatin Technologies' Obesity Drug Co-Administered With Eli Lilly's Blockbuster Drug Shows 4.4% Reduction In Weight
March 31, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.